500
Participants
Start Date
November 1, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2036
data collection
The study will collect basic information, diagnostic and treatment information from medical records and use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.
RECRUITING
Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin
Beijing Children's Hospital
OTHER
Tianjin People's Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Tianjin Medical University Second Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER
The Second Affiliated Hospital of Kunming Medical University
OTHER
Institute of Hematology & Blood Diseases Hospital, China
OTHER